Evidence map›Paper›PMID 29592783›Full record

ArticleMolecular pain

Synergistic activation of ERK1/2 between A-fiber neurons and glial cells in the DRG contributes to pain hypersensitivity after tissue injury.

Shunsuke Yamakita, Yasuhiko Horii, Hitomi Takemura, Yutaka Matsuoka, Ayahiro Yamashita, Yosuke Yamaguchi, Megumi Matsuda, Teiji Sawa, Fumimasa Amaya

Open access · goldAbstract read
In one paragraph

Article in Molecular pain. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Metabolic Transporters in the Peripheral Nerve-What, Where, and Why?Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  14. Review
  15. Purinergic Signaling in Endometriosis-Associated Pain.International journal of molecular sciences · 2020
    Review
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shunsuke Yamakita1 Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Yasuhiko Horii1 Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Hitomi Takemura1 Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Yutaka Matsuoka1 Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Ayahiro Yamashita1 Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Yosuke Yamaguchi1 Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Megumi Matsuda1 Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Teiji Sawa1 Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Fumimasa Amaya1 Department of Anesthesiology, Kyoto Prefectural University of Medicine, Kyoto, Japan.ORCID 0000-0003-2934-0845
Kyoto Prefectural University of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Intense nociceptive signaling arising from ongoing injury activates primary afferent nociceptive systems to generate peripheral sensitization. ERK1/2 phosphorylation in dorsal root ganglion can be used to visualize intracellular signal activity immediately after noxious stimulation. The aim of this study was to investigate spatiotemporal characteristics of ERK1/2 phosphorylation against tissue injury in the primary afferent neurons. Methods Plantar incisions were made in the hind paws of Sprague-Dawley rats (n =150). Levobupivacaine was injected into the plantar aspect of the paws and ankles, Mitogen-activated protein kinase kinase (MEK) inhibitor was injected into the paw, and carbenoxolone, dual inhibitor of the gap junction and pannexin channel, was intraperitoneally injected. Pain hypersensitivity was investigated by a behavioral study, while phosphorylated ERK1/2 was detected in dorsal root ganglion and hind paw using immunohistochemistry and Western blot. Results Phosphorylated ERK1/2 was induced in dorsal root ganglion (26.8 ± 2.9% at baseline, 65.6 ± 3.6% at 2 min, and 26.3 ± 3.4% at 2 h) after the incision. NF-200 positive A-fiber neurons and satellite glial cells were positive for phosphorylated ERK1/2. Injury-induced pain hypersensitivity was abolished by MEK inhibitor. Levobupivacaine treatment inhibited phosphorylated ERK1/2 induction, carbenoxolone treatment inhibited glial phosphorylated ERK1/2 at 2 min after the injury, and carbenoxolone inhibited pain hypersensitivity and neuronal phosphorylated ERK1/2 at 1 h after the injury. Conclusion ERK1/2 phosphorylation in A-fiber neurons and satellite glial cells immediately after injury contributes to the generation of pain hypersensitivity. Signal communication between neurons and satellite glial cells expands the duration of neuronal ERK1/2 phosphorylation and pain hypersensitivity at 1 h after tissue injury.

Indexed as

AnalgesicsAnimalsBupivacaineEnzyme ActivationExtracellular Signal-Regulated MAP KinasesExtremitiesGanglia, SpinalHypersensitivityMaleMitogen-Activated Protein Kinase KinasesNeurogliaNeuronsPainProtein Kinase InhibitorsRats, Sprague-DawleyAnalgesicsBupivacaineExtracellular Signal-Regulated MAP KinasesMitogen-Activated Protein Kinase KinasesProtein Kinase InhibitorsA-fiberhyperalgesiasatellite glial cellTissue injury

Identifiers

PMID29592783
PMCPMC5881964
OpenAlexW2794911665

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.